Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
H7N9 avian influenza vaccine
- Development stage
- Unknown
- Lead developer
- Moderna
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Intramuscular, Intranasal
01
Overview
The **H7N9 avian influenza vaccine** is an investigational vaccine developed to protect against infection caused by the H7N9 subtype of avian influenza A virus[1][6]. It includes formulations such as a live attenuated vaccine (H7N9 A/Anhui/13 ca) and an mRNA-based vaccine (mRNA-1018)[1][6]. The mRNA vaccine uses the mRNA platform to encode the hemagglutinin (HA) protein of the H7N9 virus, stimulating an immune response to prevent infection. The live attenuated vaccine uses a weakened form of the virus to stimulate immunity. The primary indication is prevention of pandemic influenza caused by H7N9[1][6].
- Other names
- H7N9 A/Anhui/13 ca influenza virus vaccinemRNA-1018mRNA1018mRNA 1018H7N9 influenza vaccineH-7N9 influenza vaccineH 7N9 influenza vaccineH7N9 bird flu vaccineH-7N9 bird flu vaccineH 7N9 bird flu vaccine
02
Targets
HA (Hemagglutinin)
Beyond the preview
Go deeper on H7N9 avian influenza vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on H7N9 avian influenza vaccine.